Shareholders that lost money on Corcept Therapeutics Incorporated(CORT) should contact Levi & Korsinsky about Securities Fraud Investigation - CORT
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept ...
Fierce Pharma2h
Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program
As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...
Investor's Business Daily on MSN3h
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength
Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
China Daily Global Edition8h
Teva, Kerry Pharma sign strategic partnership to build 4PL New Model, offering better solutions for patients in GBA
The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry ...